Alzamend Neuro, Inc. (ALZN) Total Assets by Year
Alzamend Neuro, Inc. closed fiscal year 2026 with $2.1M in total assets, $1.3M in total liabilities and $733K in shareholder equity. This represents a decrease of 54.8% from the prior fiscal year. The table below carries 7 fiscal years, from 2020 to 2026, and the quarters Alzamend Neuro, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ALZN Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2610-K | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K |
|---|---|---|---|---|---|---|---|
| Total Assets | $2.1M-54.8% | $4.6M+628.8% | $632K-89.3% | $5.9M-59.2% | $14.5M+398.4% | $2.9M+60.6% | $1.8M |
| Total Liabilities | $1.3M+112.1% | $635K-80.3% | $3.2M+12.4% | $2.9M+146.4% | $1.2M+29.5% | $900K-9.3% | $992K |
| Total Equity | $733K-81.5% | $4.0M+253.0% | -$2.6M-185.2% | $3.0M-77.2% | $13.4M+563.3% | $2.0M+145.0% | $822K |
ALZN Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.5M+35.0% | $2.1M-54.8% | $4.0M-3.2% | $5.1M+1.7% | $6.3M+278.9% | $4.6M+628.8% | $4.2M+433.5% | $5.0M+409.1% | $1.7M-36.5% | $632K-89.3% | $783K-90.8% | $984K-90.6% |
| Total Liabilities | $2.7M+178.6% | $1.3M+112.1% | $1.9M+155.9% | $717K-42.8% | $983K-65.9% | $635K-80.3% | $726K-85.6% | $1.3M-65.8% | $2.9M+5.2% | $3.2M+12.4% | $5.0M+91.0% | $3.7M+123.9% |
| Total Equity | $5.8M+8.6% | $733K-81.5% | $2.2M-36.2% | $4.4M+16.6% | $5.3M+540.8% | $4.0M+253.0% | $3.4M+180.9% | $3.8M+239.9% | -$1.2M-974.0% | -$2.6M-185.2% | -$4.3M-172.8% | -$2.7M-130.5% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Alzamend Neuro, Inc. financials
Frequently Asked Questions
What was Alzamend Neuro, Inc.'s total assets in fiscal year 2026?
Alzamend Neuro, Inc. closed fiscal year 2026 with $2.1M in total assets, $1.3M in total liabilities and $733K in shareholder equity.
How fast is Alzamend Neuro, Inc.'s total assets growing?
Alzamend Neuro, Inc. (ALZN) total assets fell by 54.8% year over year, from $4.6M to $2.1M in fiscal year 2026.
How has Alzamend Neuro, Inc.'s total assets changed over the years?
Across the 7 fiscal years this page covers, Alzamend Neuro, Inc. (ALZN) total assets went from $1.8M in fiscal year 2020 to $2.1M in fiscal year 2026.
What was Alzamend Neuro, Inc.'s total assets in the most recent quarter?
Alzamend Neuro, Inc. (ALZN) reported $8.5M in total assets in Q1 2027. This represents an increase of 35.0% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Alzamend Neuro, Inc. (ALZN) reported on that line in every period on record.